access: youtube, provided by access: technology

Search Results

๐–๐ก๐š๐ญ ๐ข๐ฌ ๐‹๐ž๐ฏ๐จ๐๐จ๐ฉ๐š ๐ˆ๐ง๐Ÿ๐ฎ๐ฌ๐ข๐จ๐ง ๐“๐ก๐ž๐ซ๐š๐ฉ๐ฒ? | ๐๐š๐ซ๐ค๐ข๐ง๐ฌ๐จ๐ง'๐ฌ ๐ƒ๐ข๐ฌ๐ž๐š๐ฌ๐ž ๐“๐ซ๐ž๐š๐ญ๐ฆ๐ž๐ง๐ญ ๐…๐€๐'๐ฌ

๐–๐ก๐š๐ญ ๐ข๐ฌ ๐‹๐ž๐ฏ๐จ๐๐จ๐ฉ๐š ๐ˆ๐ง๐Ÿ๐ฎ๐ฌ๐ข๐จ๐ง ๐“๐ก๐ž๐ซ๐š๐ฉ๐ฒ? | ๐๐š๐ซ๐ค๐ข๐ง๐ฌ๐จ๐ง'๐ฌ ๐ƒ๐ข๐ฌ๐ž๐š๐ฌ๐ž ๐“๐ซ๐ž๐š๐ญ๐ฆ๐ž๐ง๐ญ ๐…๐€๐'๐ฌ
๐ƒ๐ž๐ž๐ฉ ๐๐ซ๐š๐ข๐ง ๐’๐ญ๐ข๐ฆ๐ฎ๐ฅ๐š๐ญ๐ข๐จ๐ง ๐ฏ๐ฌ ๐‹๐ž๐ฏ๐จ๐๐จ๐ฉ๐š ๐ˆ๐ง๐Ÿ๐ฎ๐ฌ๐ข๐จ๐ง ๐“๐ก๐ž๐ซ๐š๐ฉ๐ฒ | ๐๐š๐ซ๐ค๐ข๐ง๐ฌ๐จ๐ง'๐ฌ ๐ƒ๐ข๐ฌ๐ž๐š๐ฌ๐ž ๐“๐ซ๐ž๐š๐ญ๐ฆ๐ž๐ง๐ญ ๐…๐€๐'๐ฌ

๐ƒ๐ž๐ž๐ฉ ๐๐ซ๐š๐ข๐ง ๐’๐ญ๐ข๐ฆ๐ฎ๐ฅ๐š๐ญ๐ข๐จ๐ง ๐ฏ๐ฌ ๐‹๐ž๐ฏ๐จ๐๐จ๐ฉ๐š ๐ˆ๐ง๐Ÿ๐ฎ๐ฌ๐ข๐จ๐ง ๐“๐ก๐ž๐ซ๐š๐ฉ๐ฒ | ๐๐š๐ซ๐ค๐ข๐ง๐ฌ๐จ๐ง'๐ฌ ๐ƒ๐ข๐ฌ๐ž๐š๐ฌ๐ž ๐“๐ซ๐ž๐š๐ญ๐ฆ๐ž๐ง๐ญ ๐…๐€๐'๐ฌ
๐ˆ๐ฌ ๐ฅ๐ž๐ฏ๐จ๐๐จ๐ฉ๐š ๐ข๐ง๐Ÿ๐ฎ๐ฌ๐ข๐จ๐ง ๐ญ๐ก๐ž๐ซ๐š๐ฉ๐ฒ ๐ฌ๐š๐Ÿ๐ž๐ซ ๐ญ๐ก๐š๐ง ๐ƒ๐ž๐ž๐ฉ ๐๐ซ๐š๐ข๐ง ๐’๐ญ๐ข๐ฆ๐ฎ๐ฅ๐š๐ญ๐ข๐จ๐ง? | ๐๐š๐ซ๐ค๐ข๐ง๐ฌ๐จ๐ง'๐ฌ ๐“๐ซ๐ž๐š๐ญ๐ฆ๐ž๐ง๐ญ ๐…๐€๐'๐ฌ

๐ˆ๐ฌ ๐ฅ๐ž๐ฏ๐จ๐๐จ๐ฉ๐š ๐ข๐ง๐Ÿ๐ฎ๐ฌ๐ข๐จ๐ง ๐ญ๐ก๐ž๐ซ๐š๐ฉ๐ฒ ๐ฌ๐š๐Ÿ๐ž๐ซ ๐ญ๐ก๐š๐ง ๐ƒ๐ž๐ž๐ฉ ๐๐ซ๐š๐ข๐ง ๐’๐ญ๐ข๐ฆ๐ฎ๐ฅ๐š๐ญ๐ข๐จ๐ง? | ๐๐š๐ซ๐ค๐ข๐ง๐ฌ๐จ๐ง'๐ฌ ๐“๐ซ๐ž๐š๐ญ๐ฆ๐ž๐ง๐ญ ๐…๐€๐'๐ฌ
๐—ฃ๐—ฎ๐—ฟ๐—ธ๐—ถ๐—ป๐˜€๐—ผ๐—ป'๐˜€ ๐——๐—ถ๐˜€๐—ฒ๐—ฎ๐˜€๐—ฒ ๐—ง๐—ฟ๐—ฒ๐—ฎ๐˜๐—บ๐—ฒ๐—ป๐˜ ๐—ถ๐—ป ๐——๐˜‚๐—ฏ๐—ฎ๐—ถ - ๐—Ÿ๐—ฒ๐˜ƒ๐—ผ๐—ฑ๐—ผ๐—ฝ๐—ฎ ๐—œ๐—ป๐—ณ๐˜‚๐˜€๐—ถ๐—ผ๐—ป ๐—ง๐—ต๐—ฒ๐—ฟ๐—ฎ๐—ฝ๐˜†

๐—ฃ๐—ฎ๐—ฟ๐—ธ๐—ถ๐—ป๐˜€๐—ผ๐—ป'๐˜€ ๐——๐—ถ๐˜€๐—ฒ๐—ฎ๐˜€๐—ฒ ๐—ง๐—ฟ๐—ฒ๐—ฎ๐˜๐—บ๐—ฒ๐—ป๐˜ ๐—ถ๐—ป ๐——๐˜‚๐—ฏ๐—ฎ๐—ถ - ๐—Ÿ๐—ฒ๐˜ƒ๐—ผ๐—ฑ๐—ผ๐—ฝ๐—ฎ ๐—œ๐—ป๐—ณ๐˜‚๐˜€๐—ถ๐—ผ๐—ป ๐—ง๐—ต๐—ฒ๐—ฟ๐—ฎ๐—ฝ๐˜†
Young Onset Parkinsonโ€™s Treatment - Levodopa Infusion Therapy

Young Onset Parkinsonโ€™s Treatment - Levodopa Infusion Therapy
๐ˆ๐ฌ ๐ฅ๐ž๐ฏ๐จ๐๐จ๐ฉ๐š ๐ข๐ง๐Ÿ๐ฎ๐ฌ๐ข๐จ๐ง ๐š๐ง ๐š๐ฅ๐ญ๐ž๐ซ๐ง๐š๐ญ๐ข๐ฏ๐ž ๐ญ๐จ ๐ƒ๐ž๐ž๐ฉ ๐๐ซ๐š๐ข๐ง ๐’๐ญ๐ข๐ฆ๐ฎ๐ฅ๐š๐ญ๐ข๐จ๐ง? ๐๐š๐ซ๐ค๐ข๐ง๐ฌ๐จ๐ง'๐ฌ ๐ƒ๐ข๐ฌ๐ž๐š๐ฌ๐ž ๐“๐ซ๐ž๐š๐ญ๐ฆ๐ž๐ง๐ญ ๐…๐€๐'๐ฌ

๐ˆ๐ฌ ๐ฅ๐ž๐ฏ๐จ๐๐จ๐ฉ๐š ๐ข๐ง๐Ÿ๐ฎ๐ฌ๐ข๐จ๐ง ๐š๐ง ๐š๐ฅ๐ญ๐ž๐ซ๐ง๐š๐ญ๐ข๐ฏ๐ž ๐ญ๐จ ๐ƒ๐ž๐ž๐ฉ ๐๐ซ๐š๐ข๐ง ๐’๐ญ๐ข๐ฆ๐ฎ๐ฅ๐š๐ญ๐ข๐จ๐ง? ๐๐š๐ซ๐ค๐ข๐ง๐ฌ๐จ๐ง'๐ฌ ๐ƒ๐ข๐ฌ๐ž๐š๐ฌ๐ž ๐“๐ซ๐ž๐š๐ญ๐ฆ๐ž๐ง๐ญ ๐…๐€๐'๐ฌ
Subcutaneous levodopa/carbidopa infusion for Parkinson's disease

Subcutaneous levodopa/carbidopa infusion for Parkinson's disease
Updates on levodopa infusion therapies for advanced Parkinsonโ€™s disease

Updates on levodopa infusion therapies for advanced Parkinsonโ€™s disease
Parkinson's Disease Medications โ€“ Making Them Work for You

Parkinson's Disease Medications โ€“ Making Them Work for You
What's New in Parkinson's Research - UF PD Educational Symposium 2024

What's New in Parkinson's Research - UF PD Educational Symposium 2024
๐–๐ก๐š๐ญ ๐ข๐ฌ ๐ƒ๐ž๐ž๐ฉ ๐๐ซ๐š๐ข๐ง ๐’๐ญ๐ข๐ฆ๐ฎ๐ฅ๐š๐ญ๐ข๐จ๐ง (๐ƒ๐๐’)? | ๐ƒ๐ž๐ž๐ฉ ๐๐ซ๐š๐ข๐ง ๐’๐ญ๐ข๐ฆ๐ฎ๐ฅ๐š๐ญ๐ข๐จ๐ง ๐ฏ๐ฌ ๐‹๐ž๐ฏ๐จ๐๐จ๐ฉ๐š ๐ˆ๐ง๐Ÿ๐ฎ๐ฌ๐ข๐จ๐ง ๐“๐ก๐ž๐ซ๐š๐ฉ๐ฒ ๐…๐€๐'๐ฌ

๐–๐ก๐š๐ญ ๐ข๐ฌ ๐ƒ๐ž๐ž๐ฉ ๐๐ซ๐š๐ข๐ง ๐’๐ญ๐ข๐ฆ๐ฎ๐ฅ๐š๐ญ๐ข๐จ๐ง (๐ƒ๐๐’)? | ๐ƒ๐ž๐ž๐ฉ ๐๐ซ๐š๐ข๐ง ๐’๐ญ๐ข๐ฆ๐ฎ๐ฅ๐š๐ญ๐ข๐จ๐ง ๐ฏ๐ฌ ๐‹๐ž๐ฏ๐จ๐๐จ๐ฉ๐š ๐ˆ๐ง๐Ÿ๐ฎ๐ฌ๐ข๐จ๐ง ๐“๐ก๐ž๐ซ๐š๐ฉ๐ฒ ๐…๐€๐'๐ฌ
Emerging subcutaneous infusions for PD: efficacy & infusion site reactions

Emerging subcutaneous infusions for PD: efficacy & infusion site reactions